• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症生物标志物与乳腺癌风险:嵌套在 EPIC-Varese 队列中的病例对照研究。

Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.

机构信息

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Medical Sciences Department, University of Torino, Torino, Italy.

出版信息

Sci Rep. 2017 Oct 5;7(1):12708. doi: 10.1038/s41598-017-12703-x.

DOI:10.1038/s41598-017-12703-x
PMID:28983080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5629213/
Abstract

Breast cancer (BC) is the leading cause of cancer death in women. Adipokines, and other inflammation molecules linked to adiposity, are suspected to be involved in breast carcinogenesis, however prospective findings are inconclusive. In a prospective nested case-control study within the EPIC-Varese cohort, we used conditional logistic regression to estimate rate ratios (RRs) for BC, with 95% confidence intervals (CI), in relation to plasma levels of C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6, leptin, and adiponectin, controlling for BC risk factors. After a median 14.9 years, 351 BC cases were identified and matched to 351 controls. No marker was significantly associated with BC risk overall. Significant interactions between menopausal status and CRP, leptin, and adiponectin were found. Among postmenopausal women, high CRP was significantly associated with increased BC risk, and high adiponectin with significantly reduced risk. Among premenopausal women, high TNF-α was associated with significantly increased risk, and high leptin with reduced risk; interleukin-6 was associated with increased risk only in a continuous model. These findings constitute further evidence that inflammation plays a role in breast cancer. Interventions to lower CRP, TNF-α, and interleukin-6 and increase adiponectin levels may contribute to preventing BC.

摘要

乳腺癌(BC)是女性癌症死亡的主要原因。脂肪因子和其他与肥胖相关的炎症分子被怀疑参与乳腺癌的发生,但前瞻性研究结果尚无定论。在 EPIC-Varese 队列的一项前瞻性嵌套病例对照研究中,我们使用条件逻辑回归来估计与 C 反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6、瘦素和脂联素血浆水平相关的 BC 发生率比(RR),并控制了 BC 的危险因素。中位随访 14.9 年后,确定了 351 例 BC 病例,并与 351 例对照相匹配。没有标志物与总体 BC 风险显著相关。在绝经状态和 CRP、瘦素和脂联素之间发现了显著的相互作用。在绝经后妇女中,高 CRP 与 BC 风险增加显著相关,而高脂联素与风险降低显著相关。在绝经前妇女中,高 TNF-α与显著增加的风险相关,高瘦素与降低的风险相关;白细胞介素-6 仅在连续模型中与增加的风险相关。这些发现进一步证明了炎症在乳腺癌中的作用。降低 CRP、TNF-α 和白细胞介素-6 并增加脂联素水平的干预措施可能有助于预防 BC。

相似文献

1
Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.炎症生物标志物与乳腺癌风险:嵌套在 EPIC-Varese 队列中的病例对照研究。
Sci Rep. 2017 Oct 5;7(1):12708. doi: 10.1038/s41598-017-12703-x.
2
Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.循环脂肪因子和炎症标志物与绝经后乳腺癌风险。
J Natl Cancer Inst. 2015 Jul 16;107(9). doi: 10.1093/jnci/djv169. Print 2015 Sep.
3
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.循环炎症生物标志物、脂肪因子与乳腺癌风险——一项嵌套于欧洲癌症与营养前瞻性调查(EPIC)队列中的病例对照研究
BMC Med. 2022 Apr 18;20(1):118. doi: 10.1186/s12916-022-02319-y.
4
Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.绝经前瘦素、脂联素、C 反应蛋白与乳腺癌发病风险的关系。
Cancer Prev Res (Phila). 2013 Mar;6(3):188-95. doi: 10.1158/1940-6207.CAPR-12-0374.
5
Increased TNF α, IL-6 and ErbB2 mRNA expression in peripheral blood leukocytes from breast cancer patients.乳腺癌患者外周血白细胞中肿瘤坏死因子α、白细胞介素-6和表皮生长因子受体2信使核糖核酸表达增加。
Med Oncol. 2014 Aug;31(8):38. doi: 10.1007/s12032-014-0038-0. Epub 2014 Jun 25.
6
Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.抵抗素、内脂素、脂联素和瘦素:沙特绝经前后女性患乳腺癌的风险及其作为新型生物标志物的可能诊断和预测意义
Dis Markers. 2015;2015:253519. doi: 10.1155/2015/253519. Epub 2015 Mar 8.
7
Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.脂肪细胞因子、炎症与绝经后妇女乳腺癌风险:一项前瞻性研究。
Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1319-24. doi: 10.1158/1055-9965.EPI-12-1444. Epub 2013 May 7.
8
Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.脂肪因子和炎症标志物与分化型甲状腺癌的风险:EPIC 研究。
Int J Cancer. 2018 Apr 1;142(7):1332-1342. doi: 10.1002/ijc.31172. Epub 2017 Dec 20.
9
A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.中介分析:肥胖和脂联素与绝经后乳腺癌风险的关系:国际乳腺癌干预研究 II(IBIS-II)预防试验中的嵌套队列研究。
Nutrients. 2024 Jun 30;16(13):2098. doi: 10.3390/nu16132098.
10
Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.腹膜透析患者的脂肪因子、内皮功能障碍与营养状况
Scand J Urol Nephrol. 2010 Dec;44(6):445-51. doi: 10.3109/00365599.2010.504191. Epub 2010 Jul 13.

引用本文的文献

1
Expression Profile of , , , and in Breast Tumors.乳腺癌中、、、和的表达谱。 (你原文中这几个“,”处应该是有具体基因名称的,这里没显示完整信息)
Int J Mol Sci. 2025 Aug 14;26(16):7841. doi: 10.3390/ijms26167841.
2
Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice.抑制脂肪细胞中的炎症会加速小鼠乳腺肿瘤的发展。
J Clin Invest. 2025 Jun 17;135(16). doi: 10.1172/JCI187202.
3
The influence of menopause age on gynecologic cancer risk: a comprehensive analysis using NHANES data.绝经年龄对妇科癌症风险的影响:使用美国国家健康与营养检查调查(NHANES)数据的综合分析
Front Oncol. 2025 Feb 11;15:1541585. doi: 10.3389/fonc.2025.1541585. eCollection 2025.
4
The evaluation of the inflammatory status and systemic antioxidant-oxidant balance of women with breast cancer during adjuvant chemotherapy.辅助化疗期间乳腺癌女性患者炎症状态及全身抗氧化-氧化平衡的评估
Rep Pract Oncol Radiother. 2024 Oct 3;29(4):488-500. doi: 10.5603/rpor.102130. eCollection 2024.
5
Proinflammatory dietary pattern and risk of total and subtypes of breast cancer among US women.美国女性中促炎饮食模式与乳腺癌总体及各亚型风险
J Natl Cancer Inst. 2025 Apr 1;117(4):701-712. doi: 10.1093/jnci/djae301.
6
Epigenetic aging differentially impacts breast cancer risk by self-reported race.表观遗传衰老通过自我报告的种族差异影响乳腺癌风险。
PLoS One. 2024 Oct 24;19(10):e0308174. doi: 10.1371/journal.pone.0308174. eCollection 2024.
7
Combined influence of nutritional and inflammatory status and breast cancer: findings from the NHANES.营养和炎症状态与乳腺癌的综合影响:来自 NHANES 的研究结果。
BMC Public Health. 2024 Aug 19;24(1):2245. doi: 10.1186/s12889-024-19727-9.
8
Adherence to Diet Quality Indices and Breast Cancer Risk in the Italian ORDET Cohort.意大利ORDET队列中饮食质量指数的依从性与乳腺癌风险
Nutrients. 2024 Apr 17;16(8):1187. doi: 10.3390/nu16081187.
9
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.白细胞介素-6/ C 反应蛋白水平的升高与腺苷途径的上调有关,并可作为非小细胞肺癌对免疫检查点抑制剂治疗产生耐药性的潜在标志物。
J Immunother Cancer. 2023 Oct;11(10). doi: 10.1136/jitc-2023-007310.
10
Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer.白细胞介素-6与其他标志物在卵巢癌诊断中的比较
J Pers Med. 2023 Jun 11;13(6):980. doi: 10.3390/jpm13060980.

本文引用的文献

1
Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort.低度炎症、氧化应激与绝经后浸润性乳腺癌风险——来自马尔默饮食与癌症队列的一项巢式病例对照研究
PLoS One. 2016 Jul 8;11(7):e0158959. doi: 10.1371/journal.pone.0158959. eCollection 2016.
2
Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies.多种恶性肿瘤中循环脂联素水平:107项研究的最新荟萃分析
Oncotarget. 2016 Jul 26;7(30):48671-48691. doi: 10.18632/oncotarget.8932.
3
Anticoagulants used in plasma collection affect adipokine multiplexed measurements.血浆采集过程中使用的抗凝剂会影响脂肪因子多重检测结果。
Cytokine. 2016 Apr;80:43-7. doi: 10.1016/j.cyto.2016.03.001. Epub 2016 Mar 3.
4
Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.诊断前高敏C反应蛋白与乳腺癌风险、复发及生存
Breast Cancer Res Treat. 2016 Jan;155(2):345-54. doi: 10.1007/s10549-015-3671-1. Epub 2016 Jan 6.
5
Circulating C-Reactive Protein and Breast Cancer Risk-Systematic Literature Review and Meta-analysis of Prospective Cohort Studies.循环C反应蛋白与乳腺癌风险——前瞻性队列研究的系统文献综述和荟萃分析
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1439-49. doi: 10.1158/1055-9965.EPI-15-0324. Epub 2015 Jul 29.
6
Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.循环脂肪因子和炎症标志物与绝经后乳腺癌风险。
J Natl Cancer Inst. 2015 Jul 16;107(9). doi: 10.1093/jnci/djv169. Print 2015 Sep.
7
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.乳腺癌患者诊断前血清炎症标志物与乳腺癌风险、诊断时严重程度及生存情况的关系。
Carcinogenesis. 2015 Oct;36(10):1121-8. doi: 10.1093/carcin/bgv096. Epub 2015 Jun 30.
8
Inflammation and cancer: advances and new agents.炎症与癌症:进展与新制剂
Nat Rev Clin Oncol. 2015 Oct;12(10):584-96. doi: 10.1038/nrclinonc.2015.105. Epub 2015 Jun 30.
9
C-reactive protein and risk of breast cancer: A systematic review and meta-analysis.C反应蛋白与乳腺癌风险:一项系统评价和荟萃分析。
Sci Rep. 2015 May 22;5:10508. doi: 10.1038/srep10508.
10
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.